Murray D. Bailey
Boehringer Ingelheim (Canada)(CA)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, Monoclonal and Polyclonal Antibodies Research, Chemical Synthesis and Analysis, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus(2003)911 cited
- → Unexpected Intermolecular Pd-Catalyzed Cross-Coupling Reaction Employing Heteroaromatic Carboxylic Acids as Coupling Partners(2006)365 cited
- → Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061(2004)186 cited
- → Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1(2014)176 cited
- → Peptide-based inhibitors of the hepatitis C virus serine protease(1998)162 cited
- → A Systematic Approach to the Optimization of Substrate-Based Inhibitors of the Hepatitis C Virus NS3 Protease: Discovery of Potent and Specific Tripeptide Inhibitors(2004)122 cited
- → Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors(2000)108 cited
- → Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans(2004)103 cited
- → Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor(2014)98 cited
- → An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA(2003)91 cited